FASLG and autoimmune polyendocrinopathy: The anti-phospholipid syndrome (APS) is a systemic autoimmune disease characterized by an adaptive immune response against self membrane anionic phospholipids or associated plasma proteins resulting in the generation of anti-phospholipid specific antibodies (aPL) [1] and APS patients show a high risk for venous or arterial thrombosis.